BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 8451724)

  • 1. Radiation therapy for larynx carcinoma: long-term results of stage I glottic carcinoma.
    Chatani M; Matayoshi Y; Masaki N
    Strahlenther Onkol; 1993 Feb; 169(2):102-6. PubMed ID: 8451724
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiation therapy for early glottic carcinoma (T1N0M0). The final results of prospective randomized study concerning radiation field.
    Chatani M; Matayoski Y; Masaki N; Teshima T; Inoue To
    Strahlenther Onkol; 1996 Mar; 172(3):169-72. PubMed ID: 8721266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiation therapy for early glottic carcinoma: indication for the wedge filter.
    Chatani M; Matayoshi Y; Masaki N; Inoue T; Teshima T; Inoue T
    Strahlenther Onkol; 1993 Nov; 169(11):655-9. PubMed ID: 8248841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of early glottic and supraglottic carcinoma treated with conventional fractionation of radiotherapy.
    Inoue T; Inoue T; Ikeda H; Teshima T; Yamazaki H; Murayama S; Othani M; Ozeki S
    Strahlenther Onkol; 1993 Oct; 169(10):584-9. PubMed ID: 8235982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Radiation therapy of early glottic cancer (T1N0M0); retrospective review of historical control].
    Teshima T; Chatani M; Hata K; Inoue T
    Rinsho Hoshasen; 1989 Dec; 34(13):1603-6. PubMed ID: 2622053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical assessment of tumor clearance during radiotherapy as a prognostic factor of early glottic carcinoma.
    Inoue T; Inoue T; Ikeda H; Teshima T; Murayama S
    Strahlenther Onkol; 1992 Oct; 168(10):579-83. PubMed ID: 1440229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of accelerated fractionated irradiation for supraglottic carcinoma: assessment of results.
    Wang CC; Nakfoor BM; Spiro IJ; Martins P
    Cancer J Sci Am; 1997; 3(2):88-91. PubMed ID: 9099458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Late local recurrence after radiotherapy for tongue and early glottic carcinoma.
    Inoue T; Inoue T; Teshima T; Murayama S; Nose T; Tanaka E; Yamazaki H; Koizumi M; Kagawa K; Ozeki S; Ikeda H
    Strahlenther Onkol; 1996 Jun; 172(6):301-5. PubMed ID: 8677501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management for stage II glottic carcinoma: radiation therapy or surgery.
    Chatani M; Yoshinobu M; Masaki N; Yoshino K
    Strahlenther Onkol; 1996 Dec; 172(12):664-8. PubMed ID: 8972751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term results of radiotherapy for T1a and T1bN0M0 glottic carcinoma.
    Nomiya T; Nemoto K; Wada H; Takai Y; Yamada S
    Laryngoscope; 2008 Aug; 118(8):1417-21. PubMed ID: 18528306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of stage IV glottic carcinoma: therapeutic outcomes.
    Spector GJ; Sessions DG; Lenox J; Newland D; Simpson J; Haughey BH
    Laryngoscope; 2004 Aug; 114(8):1438-46. PubMed ID: 15280724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased local control following radiation therapy alone in early-stage glottic carcinoma with anterior commissure extension.
    Zouhair A; Azria D; Coucke P; Matzinger O; Bron L; Moeckli R; Do HP; Mirimanoff RO; Ozsahin M
    Strahlenther Onkol; 2004 Feb; 180(2):84-90. PubMed ID: 14762660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of T3N0M0 glottic carcinoma: therapeutic outcomes.
    Sessions DG; Lenox J; Spector GJ; Newland D; Simpson J; Haughey BH; Chao KS
    Laryngoscope; 2002 Jul; 112(7 Pt 1):1281-8. PubMed ID: 12169914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early glottic carcinoma: patterns and predictors of relapse after definitive radiotherapy.
    Kersh CR; Kelly MD; Hahn SS; Spaulding CA; Cantrell RW; Constable WC
    South Med J; 1990 Apr; 83(4):374-8. PubMed ID: 2321065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Definitive radiotherapy for carcinoma in situ of the true vocal cords.
    Sengupta N; Morris CG; Kirwan J; Amdur RJ; Mendenhall WM
    Am J Clin Oncol; 2010 Feb; 33(1):94-5. PubMed ID: 19738453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiation therapy for early stage (T1-T2) sarcomatoid carcinoma of true vocal cords: outcomes and patterns of failure.
    Ballo MT; Garden AS; El-Naggar AK; Gillenwater AM; Morrison WH; Goepfert H; Ang KK
    Laryngoscope; 1998 May; 108(5):760-3. PubMed ID: 9591559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Irradiated volume and arytenoid edema after radiotherapy for T1 glottic carcinoma.
    Inoue T; Inoue T; Chatani M; Teshima T
    Strahlenther Onkol; 1992 Jan; 168(1):23-6. PubMed ID: 1734586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiotherapy for patients with early-stage glottic carcinoma: univariate and multivariate analyses in a group of consecutive, unselected patients.
    Franchin G; Minatel E; Gobitti C; Talamini R; Vaccher E; Sartor G; Politi D; Trovò MG; Barzan L
    Cancer; 2003 Aug; 98(4):765-72. PubMed ID: 12910521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conservative treatment of early glottic carcinomas with exclusive radiotherapy.
    Thariat J; Bruchon Y; Bonnetain F; Barillot I; Truc G; Peignaux K; Horiot JC; Maingon P
    Cancer Radiother; 2004 Oct; 8(5):288-96. PubMed ID: 15561594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significance of pretreatment hemoglobin level in patients with T1 glottic cancer.
    Canaday DJ; Regine WF; Mohiuddin M; Zollinger W; Machtay M; Lee J; Schultz D; Rudoltz MS
    Radiat Oncol Investig; 1999; 7(1):42-8. PubMed ID: 10030623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.